These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 15741486

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    Kavoussi RJ, Coccaro EF.
    J Clin Psychiatry; 1998 Dec; 59(12):676-80. PubMed ID: 9921702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S, Paradiso E, Bogetto F.
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH.
    J Clin Psychiatry; 2004 Nov; 65(11):1515-9. PubMed ID: 15554765
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [Abstract] [Full Text] [Related]

  • 11. An open trial of valproate in borderline personality disorder.
    Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM.
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.
    Biol Psychiatry; 2005 Mar 01; 57(5):495-9. PubMed ID: 15737664
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E, Lemelin S.
    J Clin Psychiatry; 2005 Oct 01; 66(10):1298-303. PubMed ID: 16259544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.
    Arch Gen Psychiatry; 1993 May 01; 50(5):377-85. PubMed ID: 8489326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.